Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nedim Pipić"'
Publikováno v:
European Archives of Oto-Rhino-Laryngology. 251:293-296
In a prospective non-randomized study 21 patients with lower lip squamous cell carcinoma were treated with human natural leukocyte interferon (HNLI). The response rate was measured by a size reduction of more than 25% and was 81%. A complete response
Autor:
Mladen Belicza, Antica Soldo‐Belić, Nedim Pipić, Ikić D, Zvonko Kusić, Željko Ferenčić, Šime Spaventi, Vladimir Čajkovac, Ivo Padovan, Daković N, Teodora Gregurek‐Novak
Publikováno v:
International journal of dermatology. 34(1)
Background.Interferon is considered to be an important curative agent for dermatologic diseases. We report the follow-up experience of patients with basal cell or squamous cell carcinomas treated with human natural leukocyte interferon (hnli). Result
Publikováno v:
International journal of dermatology. 30(10)
Human natural leukocytic interferon (HNLI) and recombinant interferon (rIFN) alpha 2c can be used in the therapy of basal cell carcinoma. Seventy-two patients were treated for 3 to 6 weeks with a single dose of 400,000 to 1,200,000 units (HNLI) and 2
Publikováno v:
International journal of dermatology. 30(1)
Human natural leukocytic interferon and recombinant HulFN alpha 2c can be used in the therapy of squamous cell carcinoma. The duration of treatment was 3-6 weeks. A single dose was 400,000-5,000,000 units given weekly for 3-6 weeks. Clinically and hi